{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:29:57Z","timestamp":1792740597498,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1134011"],"award-info":[{"award-number":["OPP1134011"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.039","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T17:07:50Z","timestamp":1556212070000},"page":"3190-3198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-9073","authenticated-orcid":false,"given":"Johan","family":"Vekemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Crofts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-5242","authenticated-orcid":false,"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-2684","authenticated-orcid":false,"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-0748","authenticated-orcid":false,"given":"Samir K.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_2","key":"10.1016\/j.vaccine.2019.04.039_b0005","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of Group B Streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2019.04.039_b0010","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"GBS maternal colonization investigator group. maternal colonization with group b streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0015","first-page":"31359","article-title":"Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics","author":"Vekemans","year":"2018","journal-title":"Vaccine"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2019.04.039_b0020","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B Streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0025","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jinf.2018.01.006","article-title":"Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women","volume":"76","author":"Fabbrini","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2019.04.039_b0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(15)00484-3","article-title":"Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial","volume":"16","author":"Heyderman","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0040","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody kinetics and response to routine vaccinations in infants born to women who received an investigational trivalent Group B Streptococcus polysaccharide CRM197-conjugate vaccine during pregnancy","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QCO.0000000000000266","article-title":"Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections","volume":"29","author":"Dangor","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"10.1016\/j.vaccine.2019.04.039_b0050","doi-asserted-by":"crossref","unstructured":"Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res 2016; 5: 2355.","DOI":"10.12688\/f1000research.9363.1"},{"key":"10.1016\/j.vaccine.2019.04.039_b0055","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/sim.4780091208","article-title":"Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk","volume":"9","author":"Farrington","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2019.04.039_b0060","unstructured":"https:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/ucm596509.htm accessed 03 October 2018."},{"key":"10.1016\/j.vaccine.2019.04.039_b0065","unstructured":"http:\/\/www.nitag-resource.org\/uploads\/media\/default\/0001\/04\/ea8a9b08726f9733f38d83ae87b58d4de2b4f47f.pdf accessed 03 October 2018."},{"key":"10.1016\/j.vaccine.2019.04.039_b0070","unstructured":"Correlates of vaccine-induced protection: methods and implications. WHO Geneva 2013 WHO\/IVB\/13.01."},{"key":"10.1016\/j.vaccine.2019.04.039_b0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.039_b0085","first-page":"273","article-title":"The relation of age incidence to the bactericidal power of blood against the causal organism. LeRoy D. Fothergill and Joyce Wright","volume":"24","author":"Meningitis","year":"1933","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.04.039_b0090","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/biol.1994.1062","article-title":"Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines","volume":"22","author":"K\u00e4yhty","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.04.039_b0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/315870","article-title":"Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration","volume":"182","author":"Fernandez","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.04.039_b0110","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.039_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.04.039_b0120","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.04.039_b0125","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","article-title":"Use of Serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices, 2015","volume":"64","author":"MacNeil","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.04.039_b0130","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.04.039_b0135","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.04.039_b0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokkinen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cix742","article-title":"Effect of maternally derived anti-protein and anticapsular IgG antibodies on the rate of acquisition of nasopharyngeal carriage of pneumococcus in newborns","volume":"66","author":"Ojal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.039_b0160","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.68.4.544","article-title":"Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection","volume":"68","author":"Baker","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.04.039_b0165","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0170","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0180","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants","volume":"33","author":"Dangor","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.039_b0185","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/cid\/ciw377","article-title":"The Protective value of maternal Group B Streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in european maternal sera","volume":"63","author":"Fabbrini","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2019.04.039_b0190","first-page":"30659","article-title":"Review of serocorrelates of protection against infant Group B Streptococcus disease from infection studies","volume":"S1473\u20133099","author":"Le Doare","year":"2019","journal-title":"Lancet Infect Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.039_b0195","doi-asserted-by":"crossref","first-page":"F403","DOI":"10.1136\/adc.2005.090472","article-title":"Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection","volume":"91","author":"Larsson","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.vaccine.2019.04.039_b0200","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1586\/14760584.2015.1085307","article-title":"Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants","volume":"14","author":"Dangor","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.04.039_b0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/iai.32.1.56-61.1981","article-title":"Antibody to group B Streptococcus type III in human sera measured by a mouse protection test","volume":"32","author":"Baltimore","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.04.039_b0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/infdis\/156.4.655","article-title":"Immunoprophylaxis of postnatally acquired group B streptococcal sepsis in neonatal rhesus monkeys","volume":"156","author":"Hemming","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1172\/JCI117319","article-title":"Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes","volume":"94","author":"Madoff","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.04.039_b0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0002-9378(99)70305-4","article-title":"A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection","volume":"181","author":"Davies","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.04.039_b0225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/315285","article-title":"Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate","volume":"181","author":"Paoletti","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.039_b0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical-trials - definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2019.04.039_b0235","unstructured":"http:\/\/gaia-consortium.net\/ accessed 19 October 2018"},{"key":"10.1016\/j.vaccine.2019.04.039_b0240","unstructured":"Seale et al. Manuscript submitted"},{"key":"10.1016\/j.vaccine.2019.04.039_b0245","unstructured":"https:\/\/www.sgul.ac.uk\/igbs accessed 03 October 2018"},{"key":"10.1016\/j.vaccine.2019.04.039_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2288-13-29","article-title":"A threshold method for immunological correlates of protection","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.vaccine.2019.04.039_b0255","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0140-6736(16)30394-4","article-title":"Mind the gap: jumping from vaccine licensure to routine use","volume":"387","author":"O'Brien","year":"2016","journal-title":"Lancet"},{"issue":"9930","key":"10.1016\/j.vaccine.2019.04.039_b0260","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)61682-7","article-title":"Use of vaccines as probes to define disease burden","volume":"383","author":"Feikin","year":"2014","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:02Z","timestamp":1759401182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":52,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19305018"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}